SINT SINTX TECHNOLOGIES INC.

SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T

SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T

Salt Lake City, Utah, Oct. 01, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) an advanced materials company specializing in ceramics for biomedical, aerospace, and industrial applications, is pleased to announce two key executive promotions.

Effective immediately Ryan Bock, PhD has been promoted to Chief Technology Officer (CTO) of SINTX Technologies, Inc., and Ann Kutsch has been promoted to President of SINTX Technology Assessment and Transfer (SINTX TA&T), a subsidiary of SINTX.

As CTO, Dr. Bock will lead the strategic development of SINTX’s advanced materials technologies and innovation pipeline. Dr. Bock has been with SINTX since 2008, where he has played a pivotal role in driving the company’s research and development efforts, as well as advancing critical partnerships in the biomedical and industrial sectors. His promotion reflects the Company’s commitment to advancing cutting-edge ceramic technologies that meet the growing needs of global markets.

Ann Kutsch, in her new role as President of SINTX TA&T, will focus on expanding the Company’s portfolio of intellectual property and transitioning key innovations to commercialization. Ms. Kutsch has been instrumental in developing and overseeing various research and technology transfer initiatives within SINTX TA&T. Her leadership will continue to support the Company’s growth in multiple industries, including defense, aerospace, and healthcare.

“We are excited to promote both Dr. Bock and Ms. Kutsch to these critical leadership positions,” said Eric K. Olson, President and CEO of SINTX Technologies. “Their expertise and vision are integral to SINTX’s mission of advancing ceramic technologies and exploring new avenues for growth and innovation.”

These executive promotions come at a pivotal time for SINTX Technologies as the Company continues to expand its global presence and enhance its portfolio of advanced materials for a range of high-demand applications.

For more information, please visit

About SINTX Technologies, Inc.

SINTX Technologies is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and technical applications. SINTX is a global leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans since 2008. Over the past several years, SINTX has utilized strategic acquisitions and alliances to enter into new markets. The Company has manufacturing and R&D facilities in Utah and Maryland. For more information on SINTX Technologies or its materials platform, visit .

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (“PSLRA”) that are subject to a number of risks and uncertainties. Forward-looking statements can be identified by words such as: "anticipate," "believe," "project," "estimate," "expect," "strategy,” "future," "likely," "may," "should," "will" and similar references to future periods. Examples of forward-looking statements include, among others, statements we make regarding advancement of ceramic technologies and exploring new avenues for growth and innovation, and the potential to pursue growth opportunities and explore strategic opportunities.

Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date on which they are made and reflect management’s current estimates, projections, expectations and beliefs. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, difficulty in commercializing ceramic technologies and development of new product opportunities. A discussion of other risks and uncertainties that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements can be found in SINTX’s Risk Factors disclosure in its Annual Report on Form 10-K, filed with the SEC on March 27, 2024, and in SINTX’s other filings with the SEC. SINTX undertakes no obligation to publicly revise or update the forward-looking statements to reflect events or circumstances that arise after the date of this report, except as required by law.

Business and Media Inquiries for SINTX:

SINTX Technologies

801.839.3502



EN
01/10/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on SINTX TECHNOLOGIES INC.

 PRESS RELEASE

SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expa...

SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms Appointment supports acceleration of revenue opportunities from SiNERGY™ silicon nitride devices and antipathogenic fibrous material technologies SALT LAKE CITY, Utah, Feb. 18, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics and biomaterials company focused on silicon nitride (SiN) solutions for medical and other high-value applications, today announced the appointment of Ryan Elmore as President of SINTX T...

 PRESS RELEASE

SINTX Technologies to Participate in Noble Capital Markets’ Emerging G...

SINTX Technologies to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference on February 4–5 SALT LAKE CITY, Utah, Jan. 29, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics and biomaterials company focused on silicon-nitride-based medical technologies, today announced that its management team will present at the Noble Capital Markets Emerging Growth Virtual Equity Conference, to be held February 4–5, 2026. The Company’s participation comes at an important stage in its evolution, following a period o...

 PRESS RELEASE

SINTX Technologies to Participate in Sidoti & Company Investor Confere...

SINTX Technologies to Participate in Sidoti & Company Investor Conference SALT LAKE CITY, Utah, Dec. 08, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), today announced that management will be presenting at Sidoti & Company’s Year End Virtual Investor Conference, held December 10-11, 2025. Sidoti's Year End Virtual Investor ConferenceDates: December 10-11, 2025Presentation Date and Time: Wednesday, December 10, 2025 at 3:15 P.M. ETWebcast: To schedule a one-on-one meeting with SINTX Technologies’ management team, please email KCSA Strategic ...

 PRESS RELEASE

SINTX Technologies ลงนามในข้อตกลงจัดหาวัสดุกับ EVONIK เพื่อผลิตสารประก...

SINTX Technologies ลงนามในข้อตกลงจัดหาวัสดุกับ EVONIK เพื่อผลิตสารประกอบซิลิคอนไนไตรด์–PEEK สำหรับรากฟันเทียมเฉพาะบุคคลที่พิมพ์ 3 มิติ โดยใช้เทคโนโลยี AI เข้าช่วย ความสำเร็จครั้งสำคัญช่วยให้สามารถผลิตอุปกรณ์ SiN/PEEK แบบกำหนดเองได้ทันที เมืองซอลต์เลกซิตี รัฐยูทาห์ วันที่ , Dec. 02, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc.  (NASDAQ: SINT) (“SINTX” หรือ “บริษัท”) ซึ่งเป็นบริษัทด้านเซรามิกส์และวัสดุชีวภาพขั้นสูง ได้ประกาศในวันนี้ว่า บริษัทได้ลงนามในข้อตกลงจัดหาวัสดุกับ Evonik Corporation (“EVONIK”) ซึ่งเป็นผู้นำระดับโลกด้านโพลิเมอร์ประสิทธิภาพสูง เพื่อผลิตสารประกอบซิลิคอนไนไตรด์–P...

 PRESS RELEASE

SINTX Technologies 与 EVONIK 签署供应协议,将生产用于人工智能辅助 3D 打印患者定制植入物的氮化硅-PEEK 复...

SINTX Technologies 与 EVONIK 签署供应协议,将生产用于人工智能辅助 3D 打印患者定制植入物的氮化硅-PEEK 复合材料 该里程碑使 SiN/PEEK 定制器械能够立即投产 犹他州盐湖城, Dec. 02, 2025 (GLOBE NEWSWIRE) -- 先进陶瓷和生物材料公司 SINTX Technologies, Inc. (NASDAQ: SINT) (简称“SINTX”或“公司”)今天宣布,已与高性能聚合物领域的全球领导企业 Evonik Corporation(简称“EVONIK”)签署供应协议,由 EVONIK 生产 SINTX 的专有氮化硅-PEEK 复合材料(SiN/PEEK,美国专利号 10806831)。该材料专为人工智能辅助的患者定制植入物增材制造而设计,并将使用 SINTX 位于美国的现有生产设施完成制造。 根据协议,EVONIK 将利用其商业规模生产能力,按照 SINTX 的规格生产 SiN/PEEK 复合材料,使 SINTX 能够立即开始制造人工智能设计 3D 打印患者定制植入物。 SINTX 公司已经收到医生提出的请求,希望该公司能为脊柱肿瘤切除术后的骨科和神经外科肿瘤患者提供用于人道主义用途的椎体置换 (VBR) 植入物。 此外,该公司计划使用 SiN/PEEK 复合材料支持患者匹配型植入物及采用传统减材制...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch